VialVIAL
Compound comparison

Epitalon (Epithalon) vs Sermorelin

Epitalon (Epithalon) and Sermorelin are both peptide compounds evaluated on Vial: Epitalon (Epithalon) is ruo with preclinical evidence, and Sermorelin is legally compoundable with clinical-trial evidence, offered by 1 and 29 verified providers respectively.

Vial summary · compiled from public records

At a glance

Epitalon (Epithalon)

Category
Peptide
FDA / legal status
RUO
Route
Not checked
1providers on Vial →

Sermorelin

Category
Peptide
FDA / legal status
Legally Compoundable
Route
Subcutaneous
29providers on Vial →

Side by side

FieldEpitalon (Epithalon)Sermorelin
CategoryPeptidePeptide
Brand namesNot checkedNot checked
FDA / legal statusRUOLegally Compoundable
Evidence tierPreclinicalClinical Trials
Administration routeNot checkedSubcutaneous
Compounding accessRUOLegally Compoundable
Providers on Vial1 listed29 listed
Typical price band$$$ to $$$

Verified providers offering each

Ranked by Vial Score, Vial’s 0 to 100 score built from federal and state public records. The score evaluates the provider, not the compound.

85+70 to 8450 to 69Under 50

About each compound

About Epitalon (Epithalon)

Epitalon (epithalamin) is a synthetic tetrapeptide developed by the St. Petersburg Institute of Bioregulation and Gerontology, with decades of Russian research suggesting telomere lengthening, pineal gland regulation, and lifespan extension in animal models. It stimulates telomerase activity — a rare property among known compounds. Human data is limited but promising for longevity applications. It is widely used in anti-aging clinics.

About Sermorelin

A synthetic analog of growth hormone-releasing hormone (GHRH), this 29-amino acid peptide stimulates the pituitary gland to produce and secrete endogenous growth hormone through binding to GHRH receptors. It functions by mimicking the N-terminal bioactive portion of native GHRH, promoting pulsatile GH release while preserving the body's natural feedback mechanisms. Primary applications include diagnostic testing of pituitary function and therapeutic use in growth hormone deficiency.

Descriptions compiled from public FDA records and manufacturer labeling where available. Not medical advice.

This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.

Related compound comparisons

Other comparisons in the same category.

All compound comparisons →